IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

Indian Pharma Network

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in
Manage My Orders

ALIQOPA (copanlisib) for Injection

ALIQOPA (copanlisib) for injection, for intravenous use Initial U.S. Approval: 2017

ALIQOPA is a kinase inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies.

Copanlisib is Generic Name for the trade name drug Aliqopa®. Aliqopa® is manufactured by Bayer HealthCare Pharmaceuticals Inc. Aliqopa® is approved by the FDA. Date of approval: September 14, 2017. Aliqopa® is supplied for injection: 60 mg as a lyophilized solid in single-dose vial for reconstitution for intravenous administration.

Medicine Name: Aliqopa
Generic Name: Copanlisib
Dosage Form & Strength: For injection: 60 mg as a lyophilized solid in single-dose vial
Manufactured By: Bayer Corporation

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import ALIQOPA (copanlisib) for Injection ” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

alpelisib tablets

alpelisib tablets, for oral use Initial U.S. Approval: 2019

As specified in the prescribing information, alpelisib tablets is indicated for the treatment of Breast Cancer.  Piqray (alpelisib) is a medication used in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.

Facts about alpelisib tablets

DISEASE INDICATIONS-Breast Cancer
MANUFACTURER-Novartis
USAGE-Oral
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “alpelisib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

ALUNBRIG (brigatinib) tablets

ALUNBRIG (brigatinib) tablets

ALUNBRIG is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. The medication Alunbrig specifically contains the active substance Brigatinib. Brigatinib basically belongs to a class of drugs named kinase inhibitors. Brigatinib specifically acts as an anaplastic lymphoma kinase (ALK) as well as epidermal growth factor receptor (EGFR) inhibitor.

Brand Name: Alunbrig
Innovator Brand Name: Alunbrig
API: Brigatinib
Packaging: 21 & 180 Tablets
Strength: 30mg
Manufacturer Name: Takeda Pharmaceutical

Access the best support services globally

The Indian Pharma helps patients in accessing or importing Brigatinib (Alunbrig), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country. If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import ALUNBRIG (brigatinib) tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

amivantamab-vmjw injection

amivantamab-vmjw injection
for intravenous use Initial U.S. Approval: 2021

Rybrevant (amivantamab-vmjw) is a prescription medicine used to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that have EGFR exon 20 insertion mutations.

Facts about amivantamab-vmjw injection

Disease Indications-Lung Cancer
Manufacturer-Janssen Biotech
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “amivantamab-vmjw injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

AMVUTTRA (vutrisiran) injection

AMVUTTRA (vutrisiran) injection, for subcutaneous use Initial U.S. Approval: 2022

AMVUTTRA is a prescription medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). AMVUTTRA is used in adults only.

Brand Name: AMVUTTRA
Generic Name: vutrisiran
Strength: Injection: 25 mg/0.5 mL in a single-dose prefilled syringe.
Manufacturer: Alnylam Pharmaceuticals
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “AMVUTTRA (vutrisiran) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for AMVUTTRA (vutrisiran) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more

apalutamide tablets

apalutamide tablets,
for oral use Initial U.S. Approval – 2018

Erleada (apalutamide) is a medication used for the treatment of non-metastatic castration-resistant prostate cancer.

Facts about apalutamide tablets

Disease Indications-Prostate Cancer
Manufacturer-Janssen Biotech
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “apalutamide tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

asparaginase erwinia chrysanthemi injection

,

asparaginase erwinia chrysanthemi (recombinant) rywn) injection, for intramuscular use Initial U.S. Approval: 2021

Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) is a prescription medicine that is a component of a multi-agent chemotherapeutic regimen used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adults and children aged 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase.

Facts about asparaginase erwinia chrysanthemi injection

Disease Indications-Leukemia, Lymphoma
Manufacturer-Jazz Pharmaceuticals
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “asparaginase erwinia chrysanthemi injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

atezolizumab injection

, ,

atezolizumab injection
for intravenous use Initial U.S. Approval: 2016

Tecentriq (atezolizumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma, for the treatment of metastatic non-small cell lung cancer (NSCLC), and for the treatment of advanced triple negative breast cancer (TNBC).

Facts about atezolizumab injection

DISEASE INDICATIONS-Urothelial Carcinoma, Breast Cancer, Lung Cancer
MANUFACTURER-Roche Registration Limited
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “atezolizumab injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

Atriance (nelarabine) Injection

, ,

Atriance (nelarabine) 5 mg/ml solution

Atriance contains nelarabine which belongs to a group of medicines known as antineoplastic agents, used in chemotherapy to kill some types of cancer cells. Atriance is used to treat patients with:

  • a type of leukaemia, called T-cell acute lymphoblastic leukaemia.
  • a type of lymphoma, called T-cell lymphoblastic lymphoma.

If you have any questions about your illness, talk to your doctor

Brand Name: On Request
Generic Name: Nelarabine.
Strength: • 250 mg/50 ml (5 mg/ml) Vial.
Manufacturer: Novartis Pharmaceuticals
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Atriance (nelarabine) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for the price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more

AUGTYRO (repotrectinib) capsules

AUGTYRO (repotrectinib) capsules, for oral use Initial U.S. Approval: 2023

AUGTYRO is used to treat a certain type of lung cancer (non-small cell lung cancer-NSCLC). Repotrectinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors.

Brand Name: AUGTYRO
Generic Name: repotrectinib
Strength: Capsules: 40 mg
Manufacturer: Bristol-Myers Squibb
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “AUGTYRO (repotrectinib) capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for AUGTYRO (repotrectinib) capsules price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in 
urgent@indianpharmanetwork.co.in